Major Win for Alzheimer’s Patients as U.S. House Committee Announces Significant Investments in Fighting Alzheimer’s

Major Win for Alzheimer’s Patients as U.S. House Committee Announces Significant Investments in Fighting Alzheimer’s

Washington, D.C. – The fight to end Alzheimer’s got a major boost today as the U.S. House Appropriations Committee passed significant funding increases for Alzheimer’s research, prevention, and treatment. This includes:

· $3.7 billion for the National Institute on Aging (NIA). The amount in the House bill is an increase of $200 million from the previous year. This funding will allow the agency to continue building on its research as it works to achieve the national goal of preventing and effectively treating Alzheimer’s by 2025;

· $35.5M for the Centers for Disease Control and Prevention’s Alzheimer’s program. An increase of $5 million, this funding will allow CDC to build on the Alzheimer’s Disease and Healthy Aging Program work to address risk factors for Alzheimer’s, promote the health of older Americans across multiple chronic conditions, and address health equity challenges for this population;

· $2.75 billion for the Advanced Research Projects Agency for Health (ARPA-H). This increase of $1.75 billion is an important investment in this newly created agency whose mission is to accelerate the development of treatments and cures for some of our country’s deadliest diseases, like cancer and Alzheimer’s.

Additionally, the bill encourages the NIA to continue its efforts to increase and diversify recruitment in Alzheimer’s clinical research, while calling on the agency to assess its efforts and report back to Congress its plans to provide more transparency in its work to make clinical trials more inclusive and representative of populations impacted by Alzheimer’s

“A budget is a statement of priorities and the Appropriations Committee made it clear today that fighting Alzheimer’s is high on the list,” said George Vradenburg, chair and co-founder of UsAgainstAlzheimer’s. “We have been fortunate to work with so many members of Congress who care deeply about this issue, some of whom are directly impacted themselves, and we appreciate their commitment to ending this horrible disease.”

After the House acts on the appropriations bill the Senate will consider its version.

# # #

About UsAgainstAlzheimer’s

UsAgainstAlzheimer’s exists to conquer Alzheimer’s disease. We take on the toughest problems; bring all of “Us” together to break down barriers; advocate for research that will speed treatments to market; and drive changes that matter most to people living with the disease. We will not rest until brain-span equals lifespan - for everyone.